NM_020812.4(DOCK6):c.6066G>C (p.Leu2022=) AND not provided
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- May 13, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002639810.3
Allele description [Variation Report for NM_020812.4(DOCK6):c.6066G>C (p.Leu2022=)]
NM_020812.4(DOCK6):c.6066G>C (p.Leu2022=)
Condition(s)
- Synonyms:
- none provided
- Identifiers:
- MedGen: C3661900
-
fibroblast growth factor receptor 2 isoform X4 [Danio rerio]
fibroblast growth factor receptor 2 isoform X4 [Danio rerio]gi|2800552278|ref|XP_068081040.1|Protein
-
PREDICTED: Danio rerio fibroblast growth factor receptor 2 (fgfr2), transcript v...
PREDICTED: Danio rerio fibroblast growth factor receptor 2 (fgfr2), transcript variant X1, mRNAgi|2800552272|ref|XM_068224937.1|Nucleotide
-
fibroblast growth factor receptor 2 isoform 1 precursor [Danio rerio]
fibroblast growth factor receptor 2 isoform 1 precursor [Danio rerio]gi|339895790|ref|NP_001229933.1|Protein
-
DNA mismatch repair protein Msh6 isoform X1 [Danio rerio]
DNA mismatch repair protein Msh6 isoform X1 [Danio rerio]gi|2800552108|ref|XP_068080998.1|Protein
-
Sequence 32748 from Patent EP2199304
Sequence 32748 from Patent EP2199304gi|300545276|emb|HC957482.1||pat|EP 304|32748Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024